EMEA-000559-PIP01-09-M04

Key facts

Invented name
Ixiaro
Active substance
Japanese encephalitis virus, inactivated (attenuated strain SA14-14-2 grown in vero cells)
Therapeutic area
Vaccines
Decision number
P/0278/2017
PIP number
EMEA-000559-PIP01-09-M04
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
Prevention of Japanese encephalitis
Route(s) of administration
Intramuscular use
Contact for public enquiries
Valneva Austria GmbH
Tel. +43 1206201286
E-mail: Christian.TAUCHER@valneva.com
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000559-PIP01-09-M04
Compliance opinion date
10/11/2017
Compliance outcome
positive

Decision

How useful was this page?

Add your rating